Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
Ryoichi Bessho, Yumi Takiyama, Takao Takiyama et al. · Scientific Reports · 2019
Full textCC BYNot checked
Nephrology
Filters3 filters applied
Status
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Readable here
1 paperQuestions on this topic